These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34948016)

  • 1. Profiling Glioblastoma Cases with an Expression of DCX, OLIG2 and NES.
    Odrzywolski A; Jarosz B; Kiełbus M; Telejko I; Ziemianek D; Knaga S; Rola R
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piwil1 Regulates Glioma Stem Cell Maintenance and Glioblastoma Progression.
    Huang H; Yu X; Han X; Hao J; Zhao J; Bebek G; Bao S; Prayson RA; Khalil AM; Jankowsky E; Yu JS
    Cell Rep; 2021 Jan; 34(1):108522. PubMed ID: 33406417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
    Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
    J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma.
    Behling F; Barrantes-Freer A; Behnes CL; Stockhammer F; Rohde V; Adel-Horowski A; Rodríguez-Villagra OA; Barboza MA; Brück W; Lehmann U; Stadelmann C; Hartmann C
    PLoS One; 2020; 15(3):e0229274. PubMed ID: 32160197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.
    Smith SJ; Diksin M; Chhaya S; Sairam S; Estevez-Cebrero MA; Rahman R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2.
    Bouchart C; Trépant AL; Hein M; Van Gestel D; Demetter P
    Cancer Med; 2020 Feb; 9(3):1069-1078. PubMed ID: 31568682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation.
    Hassani Z; Saleh A; Turpault S; Khiati S; Morelle W; Vignon J; Hugnot JP; Uro-Coste E; Legrand P; Delaforge M; Loiseau S; Clarion L; Lecouvey M; Volle JN; Virieux D; Pirat JL; Duffau H; Bakalara N
    Mol Cancer Res; 2017 Oct; 15(10):1376-1387. PubMed ID: 28634226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
    Bogeas A; Morvan-Dubois G; El-Habr EA; Lejeune FX; Defrance M; Narayanan A; Kuranda K; Burel-Vandenbos F; Sayd S; Delaunay V; Dubois LG; Parrinello H; Rialle S; Fabrega S; Idbaih A; Haiech J; Bièche I; Virolle T; Goodhardt M; Chneiweiss H; Junier MP
    Acta Neuropathol; 2018 Feb; 135(2):267-283. PubMed ID: 29149419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms.
    Trépant AL; Bouchart C; Rorive S; Sauvage S; Decaestecker C; Demetter P; Salmon I
    Tumour Biol; 2015 Mar; 36(3):1943-53. PubMed ID: 25384509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting RGS4 Ablates Glioblastoma Proliferation.
    Guda MR; Velpula KK; Asuthkar S; Cain CP; Tsung AJ
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scalable Culturing of Primary Human Glioblastoma Tumor-Initiating Cells with a Cell-Friendly Culture System.
    Li Q; Lin H; Rauch J; Deleyrolle LP; Reynolds BA; Viljoen HJ; Zhang C; Zhang C; Gu L; Van Wyk E; Lei Y
    Sci Rep; 2018 Feb; 8(1):3531. PubMed ID: 29476107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doublecortin undergo nucleocytoplasmic transport via the RanGTPase signaling to promote glioma progression.
    Ayanlaja AA; Ji G; Wang J; Gao Y; Cheng B; Kanwore K; Zhang L; Xiong Y; Kambey PA; Gao D
    Cell Commun Signal; 2020 Feb; 18(1):24. PubMed ID: 32050972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence.
    Guichet PO; Masliantsev K; Tachon G; Petropoulos C; Godet J; Larrieu D; Milin S; Wager M; Karayan-Tapon L
    J Pathol; 2018 Oct; 246(2):205-216. PubMed ID: 30009411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NHERF-1: modulator of glioblastoma cell migration and invasion.
    Kislin KL; McDonough WS; Eschbacher JM; Armstrong BA; Berens ME
    Neoplasia; 2009 Apr; 11(4):377-87. PubMed ID: 19308292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival.
    Sana J; Busek P; Fadrus P; Besse A; Radova L; Vecera M; Reguli S; Stollinova Sromova L; Hilser M; Lipina R; Lakomy R; Kren L; Smrcka M; Sedo A; Slaby O
    Sci Rep; 2018 Feb; 8(1):2836. PubMed ID: 29434344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteogenomics of glioblastoma associates molecular patterns with survival.
    Yanovich-Arad G; Ofek P; Yeini E; Mardamshina M; Danilevsky A; Shomron N; Grossman R; Satchi-Fainaro R; Geiger T
    Cell Rep; 2021 Mar; 34(9):108787. PubMed ID: 33657365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
    Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
    PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic doublecortin gene expression suppresses the malignant phenotype in glioblastoma cells.
    Santra M; Zhang X; Santra S; Jiang F; Chopp M
    Cancer Res; 2006 Dec; 66(24):11726-35. PubMed ID: 17178868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.